Cision PR Newswire, Author at World Lifestyler

No Result

View All Result

WORLD LIFESTYLER

No Result

View All Result

Home Author

Cision PR Newswire

Press Releases - Lifestyle

Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial

June 5, 2026

Press Releases - Lifestyle

Ambrosia Biosciences Announces Preclinical Data Supporting Differentiated Profile of AMB-702, its Novel Small Molecule GLP-1 Receptor Agonist Development Candidate

June 5, 2026

Press Releases - Lifestyle

Novo Nordisk’s investigational zenagamtide shows significant A1C reductions with up to 14.6% weight loss in adults with type 2 diabetes–presented at ADA 2026

June 5, 2026

Press Releases

Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

June 5, 2026

Press Releases - Food & Drink

Corner Bakery Offers $50 Off Catering for Game-Day Watch Parties

June 5, 2026

Press Releases - Lifestyle

Europe’s competitiveness hinges on integrated industrial electrification, new Eurelectric report shows

June 5, 2026

Press Releases - Lifestyle

BMI Investors Have Opportunity to Lead Badger Meter, Inc. Securities Fraud Lawsuit

June 5, 2026

Press Releases - Lifestyle

First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control

June 5, 2026

Press Releases

Corgi Launches Suite of Six Fixed Income ETFs on Cboe BZX, Capping a Week of 50 Fund Launches

June 5, 2026

Press Releases - Lifestyle

Lennar Names Jim Parker Chief Operating Officer and David Grove EVP, Homebuilding

June 5, 2026

Page 931 of 3836 Prev 1 … 930 931 932 … 3,836 Next

No Result

View All Result

Home

Cision PR Newswire

Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial

Ambrosia Biosciences Announces Preclinical Data Supporting Differentiated Profile of AMB-702, its Novel Small Molecule GLP-1 Receptor Agonist Development Candidate

Novo Nordisk’s investigational zenagamtide shows significant A1C reductions with up to 14.6% weight loss in adults with type 2 diabetes–presented at ADA 2026

Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Corner Bakery Offers $50 Off Catering for Game-Day Watch Parties

Europe’s competitiveness hinges on integrated industrial electrification, new Eurelectric report shows

BMI Investors Have Opportunity to Lead Badger Meter, Inc. Securities Fraud Lawsuit

First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control

Corgi Launches Suite of Six Fixed Income ETFs on Cboe BZX, Capping a Week of 50 Fund Launches

Lennar Names Jim Parker Chief Operating Officer and David Grove EVP, Homebuilding

Recommended

Lobos 1707 Activates 7-Day Buzzer Beater Fan Reward Program Following Phoenix Suns’ Double-Overtime Game-Winning Shot vs. Orlando Magic

Bluerock Acquisition Corp. Announces Pricing of $150 Million Initial Public Offering

Popular News

Monport Laser Engravers Support UK Makers to Create Reusable Projects During Plastic Free July

The Dolphin Company Corrects False Claims by Former Management

CCOI INVESTOR ALERT: RGRD Law Files Class Action Lawsuit Against Cogent Communications Holdings, Inc. and Announces that Investors with Substantial Losses Have Opportunity to Lead the Cogent Class Action Lawsuit

After Arrest Controversy, “Empire State Building Couple” Angela Nikolau and Ivan Beerkus to Address Recent Incident on Gosh Live

Think Bold, Ride Bold: Insta360 Takes Over the Champs-Élysées with 200-Rider Community Event

Connect with us

About & Contact

Explore Content

Legal & Privacy

Tiny Media Brands